Considering NGS-based data, the frequency of mutations for BRAF and NRAS oncogenes has been reported at even higher rates (up to more than 20%) in different types of MM, with the most prevalent incidence in the mucosae of the head and neck district (Figure 2) [29,30,31]. The gene discussed is BRAF; the disease is Miyoshi myopathy.